Lawn, SD; Kerkhoff, AD; Vogt, M; Ghebrekristos, Y; Whitelaw, A; Wood, R; (2012) Characteristics and Early Outcomes of Patients With Xpert MTB/RIF-Negative Pulmonary Tuberculosis Diagnosed During Screening Before Antiretroviral Therapy. Clinical infectious diseases, 54 (8). pp. 1071-1079. ISSN 1058-4838 DOI: https://doi.org/10.1093/cid/cir1039

Sabapathy, K; Ford, N; Chan, KN; Kyaw, MK; Elema, R; Smithuis, F; Floyd, S; (2012) Treatment Outcomes From the Largest Antiretroviral Treatment Program in Myanmar (Burma): A Cohort Analysis of Retention After Scale-Up. Journal of acquired immune deficiency syndromes (1999), 60 (2). E53-E62. ISSN 1525-4135 DOI: https://doi.org/10.1097/QAI.0b013e31824d5689 Full text not available from this repository.

Moses, M; Zachariah, R; Tayler-Smith, K; Misinde, D; Foncha, C; Manzi, M; Bauerfeind, A; Mwagomba, B; Kwanjana, J; Harries, AD; (2010) Outcomes and safety of concomitant nevirapine and rifampicin treatment under programme conditions in Malawi. The international journal of tuberculosis and lung disease, 14 (2). pp. 197-202. ISSN 1027-3719 https://researchonline.lshtm.ac.uk/id/eprint/4101 Full text not available from this repository.

Patel, TA; Lockwood, DN; (2009) Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases. Tropical medicine & international health, 14 (9). pp. 1064-1070. ISSN 1360-2276 DOI: https://doi.org/10.1111/j.1365-3156.2009.02329.x Full text not available from this repository.

Guerin, PJ; Olliaro, P; Sundar, S; Boelaert, M; Croft, SL; Desjeux, P; Wasunna, MK; Bryceson, ADM; (2002) Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. The Lancet infectious diseases, 2 (8). pp. 494-501. ISSN 1473-3099 DOI: https://doi.org/10.1016/S1473-3099(02)00347-X Full text not available from this repository.